Navigation Links
Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
Date:10/1/2007

CEO Glenn A. Oclassen to Join Sleep Experts in Panel Hosted by Natixis

Bleichroeder

PT. RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, President and Chief Executive Officer, will participate in a panel focused on middle-of-the-night (MOTN) insomnia at the Natixis Bleichroeder "Hidden Gems" Healthcare Conference.

Date: Monday, October 8, 2007

Panel Discussion: 3:45 p.m. ET

Company Presentation: 4:45 p.m. ET

Location: The Carlton Hotel at 88 Madison Avenue, New York, NY

Mr. Oclassen commented, "This is the first panel sponsored by the investment community to discuss the form of insomnia that is characterized by patients who awaken in the middle of the night and have difficulty returning to sleep. According to a recent survey conducted by the Stanford Sleep Epidemiology Research Center, it is estimated that up to 35% of Americans over the age of 18 suffer primarily from this and related forms of sleep disorder. Despite this large patient population, there is no pharmaceutical agent currently approved to treat this common sleep problem."

"Transcept is developing Intermezzo(TM) (zolpidem tartrate lozenge) for the treatment of such MOTN insomnia. In a recently completed Phase 3 sleep laboratory study, Intermezzo(TM) met the primary endpoint of decreasing sleep onset after a middle of the night awakening, without next day residual effects. I look forward to participating in this panel with these respected sleep experts and raising awareness of this aspect of insomnia."

The MOTN insomnia panel will be co-hosted by Corey Davis, Ph.D., and Jon LeCroy, M.D. of Natixis Bleichroeder. The panel of sleep experts will include Martin B. Scharf, PhD, Director, Center for Research in Sleep Disorders, Cincinnati, Ohio and Gary K. Zammit, Ph.D., Director of the Sleep Disorders Institute at St. Luke's/Roosevelt Hospital, NYC.

<
'/>"/>
SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Bruker Participates in Dutch Funded Super Microscope Project
4. Venture Investors early-stage fund grows to $115 million
5. Investor warns of angel-venture funding gap
6. Brazilian bio-industry should impress American investors
7. Investors raise $25 million for biodiesel plant
8. Bio-energy and cleantech grab attention of investors
9. Venture Investors to open Michigan office
10. Early-stage executives hear from investors
11. Commerce qualifies seven for investor tax credits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Mass. , June 2, 2015  Alere ... in rapid diagnostics, joined the White House Antibiotic ... of commitments to support and advance the President,s ... Company,s commitments include a number of measurable goals ... when achieved, will help healthcare providers protect their ...
(Date:6/2/2015)... June 02, 2015 Through rare discovery ... Yancy Corporation is enabling World Scientists to ... and biological sample, displaying the full nature (position, shape, ... atoms. , Jeff Porter, Co-Founder of the Yancy Corporation, ... that – rare. They come once in a lifetime, ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 German-based Moenninghoff ... United States distributor for the Moenninghoff product line ... “I am pleased to announce that the R.M. Hoffman ... For our firm, founded in 1916, this is a ... Hoffman is the kind of professional distributor we need ...
(Date:6/1/2015)... 2015 Chosen for his engaging ... Uldrich has been selected as keynote speaker for ... He will deliver his keynote: "Don't Stop Thinking ... presentations to the American Medical Association, Blue Cross ... Alcetel-Lucent/Verizon Forum on Wireless Healthcare, United Healthcare, IASIS ...
Breaking Biology Technology:Alere Announces Broad Initiatives to Help Combat Antibiotic Resistance during White House Antibiotic Stewardship Forum 2Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2
... Live On Company,s Website -, TUSTIN, Calif., Oct. ... clinical stage biopharmaceutical,company developing monoclonal antibodies for the treatment ... management will,present at the BIO Investor Forum 2008 on ... EDT). The conference will be held at the Palace ...
... 28 Neurocrine Biosciences,(Nasdaq: NBIX ) announces the following Webcast:, ... When: October 28, 2008 @ 5 p.m. Eastern ... How: Live over the Internet -- Simply log ... above., Contact: Claudia Woodworth, 858-617-7759 ...
... MEMY ) today announced that it has received,notice ... of the,Company,s common stock will be transferred from The ... the opening of trading on October,28, 2008. The Company,s ... The Panel has also notified the Company that it ...
Cached Biology Technology:Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 2Memory Pharmaceuticals Provides Update on NASDAQ Listing Status 2Memory Pharmaceuticals Provides Update on NASDAQ Listing Status 3
(Date:6/1/2015)... According to a new market research report ... & Touchless), Application (Consumer Electronics, Automotive, & Others), Product ... Forecast to 2020", published by MarketsandMarkets, the Gesture Recognition ... Billion by 2020, at a CAGR of 28.23% between ... data T ables and   86   F ...
(Date:6/1/2015)... 1, 2015 According to ... Market by Application (Government, Military & Defense, Healthcare, ... and Security), Technology (Face Recognition, Fingerprint Recognition, Iris ... Recognition, and Others), Function (Contact and Non-Contact) & ... Europe , APAC, Row) - Global ...
(Date:5/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/2w6zgs/facial ... "Facial Recognition Market by Solution, by Software, by ... 2020" report to their offering. ... technology become more efficient and cost effective. This ... investment from the commercial sector. The development of ...
Breaking Biology News(10 mins):Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2
... with a common condition that causes frequent nighttime ... minimally invasive treatment that shrinks the prostate, suggests a ... 38th Annual Scientific Meeting in New Orleans. The early ... prostatic artery embolization (PAE), which reduces blood flow to ...
... Inc. (OTC Markets: MDBX) ( www.medboxinc.com ), a leader ... to various medical and retail related industries worldwide, seeks ... in the mushrooming legal marijuana industry and has issued a ... past, present, and future projects. Company CEO, ...
... sea levels, new research indicates that cutting emissions of ... this century. The research team found that reductions ... atmosphere could temporarily forestall the rate of sea level ... avoid potentially dangerous sea level rise, we could cut ...
Cached Biology News:Nonsurgical treatment turns back the clock, shrinks enlarged prostate 2Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 2Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 3Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 4Medbox Positions Itself as the Leader on Wall Street in the Legalized Marijuana Industry 5Cutting specific pollutants would slow sea level rise 2Cutting specific pollutants would slow sea level rise 3
Anti-Human Factor XI Purified (Polyclonal) (sheep IgG)...
...
This antibody detects an ~25 kDa band, corresponding to the expected molecular mass of Rab3A, on immunoblots. The antibody specificity is confirmed in peptide inhibition immunoblotting studies....
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Biology Products: